Instruments for the Evaluation of Symptoms in Cancer Patients

Referencias bibliográficas

• Aaronson NK, Bullinger M, Ahmedzai S (1988) A modular approach to quality of life assessment in cancer clinical trials. Recent Results Cancer Res 111:231–249
• Aaronson NK, Ahmedzai S, Bullinger M (1991) The EORTC core quality of life questionnaire: Interim results of an international field study. In: Osoba D (ed) Effect of Cancer on Quality of Life. CRC Press, Boca Raton, FL, pp 185–203
• Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376
• Abu-Saad Huijer H, Sagherian K, Tamim H (2014) Validation of the Arabic version of the memorial symptom assessment scale among Lebanese cancer patients. J Pain Symptom Manag 50:559. https://doi.org/10.1016/j.jpainsymman.2014.08.014
• Agra Y, Badía X (1999) Evaluación de las propiedades psicométricas de la versión española del Rotterdam Symptom Checklist para medir calidad de vida en personas con cáncer. Rev Esp Salud Pública 73(1):35–44
• Anisimov VN, Sikora E, Pawelec G (2009) Relationships between cancer and aging: a multilevel approach. Biogerontology 10(4):323–338
• Arrarás JI, Arias F, Tejedor M, Pruja E, Marcos M, Martínez E et al (2002) The EORTC QLQ-C30 (version 3.0) Quality of Life questionnaire: validation study for Spain with head and neck cancer patients. Psychooncology 11(3):249–256
• Arrarás JI, Villafranca E, Arias F, Domínguez MA, Lainez N, Manterola A et al (2008) The EORTC quality of life questionnaire QLQ-C30 (version 3.0). Validation study for Spanish prostate cancer patients. Arch Esp Urol 61(8):949–954
• Arseven A, Chang CH, Arseven OK, Emanuel LL (2005) Assessment instruments. Clin Geriatr Med 21(1):121–146
• Ascunce N, Salas D, Zubizarreta R, Almazán R, Ibáñez J, Ederra M et al (2010) Cancer screening in Spain. Ann Oncol 21 Suppl 3:iii43-51
• Ashbury FD, Findlay H, Reynolds B, McKerracher K (1998) A Canadian survey of cancer patients’ experiences: are their needs being met? J Pain Symptom Manag 16(5):298–306
• Badía X, Muriel C, Gracia A, Núñez-Olarte JM, Perulero N, Gálvez R et al (2003) Validación española del cuestionario Brief Pain Inventory en pacientes con dolor de causa neoplásica. Med Clin (Barc) 120(2):52–59
• Baró E, Carulla J, Cassinello J, Colomer R, Mata JG, Gascón P et al (2009) Development of a new questionnaire to assess patient perceptions of cancer related fatigue: item generation and item reduction. Value Health 12(1):130–138
• Baró E, Carulla J, Cassinello J, Colomer R, Mata JG, Gascón P et al (2011) Psychometric properties of the perform questionnaire: a brief scale for assessing patient perceptions of fatigue in cancer. Support Care Cancer 19(5):657–666
• Brescia FJ, Adler D, Gray G, Ryan MA, Cimino J, Mamtani R (1990) Hospitalized advanced cancer patients: a profile. J Pain Symptom Manag 5(4):221–227
• Browall M, Kenne-Sarenmalm E, Nasic S, Wengström Y, Gaston-Johansson F (2013) Validity and reliability of the Swedish version of the memorial symptom assessment scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics and distress. J Pain Symptom Manag 46(1):131–141
• Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6–9
• Caro I, Ibáñez E (1992) La escala Hospitalaria de Ansiedad y Depresión. Su utilidad práctica en Psicología de la Salud. Boletín de Psicología 36:43–69
• Carvajal A, Centeno C, Watson R, Bruera E (2011) A comprehensive study of psychometric properties of the Edmonton Symptom Assessment System (ESAS) in Spanish advanced cancer patients. Eur J Cancer 47(12):1863–1872
• Chang VT, Hwang SS, Feuerman M, Kasimis BS, Thaler HT (2000a) The memorial symptom assessment scale short form (MSAS-SF). Cancer 89(5):1162–1171
• Chang VT, Hwang SS, Feuerman M (2000b) Validation of the Edmonton Symptom Assessment Scale. Cancer 88(9):2164–2171
• Chang VT, Hwang SS, Kasimis BS, Thaler HT (2004) Shorter symptom assessment instruments: the Condensed Memorial Symptom Assessment Scale (CMSAS). Cancer Investig 22(4):526–536
• Cheng KK, Wong EM, Ling WM, Chan CW, Thompson DR (2009) Measuring the symptom experience of Chinese cancer patients: a validation of the Chinese version of the memorial symptom assessment scale. J Pain Symptom Manag 37(1):44–57
• Cleeland CS (1991) Pain assessment in cancer. In: Osoba D (ed) Effect of cancer on quality of life. CRC Press, Boca Raton, pp 293–305
• Cleeland CS, Ryan KM (1994) Pain assessment: global use of th Brief Pain Inventory. Ann Acad Med Singap 23(2):129–138
• Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M et al (2000) Assessing symptom distress in cancer patients: the M. D. Anderson Symptom Inventory. Cancer 89(7):1634–1646
• Collins JJ, Byrnes ME, Dunkel IJ, Lapin J, Nadel T, Thaler HT et al (2000) The measurement of symptoms in children with cancer. J Pain Symptom Manag 19(5):363–377
• Collins JJ, Devine TD, Dick GS, Johnson EA, Kilham HA, Pinkerton CR et al (2002) The measurement of symptoms in young children con cancer: the validation of the memorial symptom assessment scale in children aged 7–12. J Pain Symptom Manag 23(1):10–16
• Correia FR, De Carlo MMRP (2012) Evaluación de la calidad de vida en contexto de los cuidados paliativos: revisión integradora de literatura. Rev Latino-Am Enfermagem 20(2):[10 pantallas]
• Curtis EB, Krech R, Walsh TD (1991) Common symptoms in patients with advanced cancer. J Palliat Care 7(2):25–29
• Daut RL, Cleeland CS, Flanery RC (1983) Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 17(2):197–210
• De Haes JCJM, Pruyn JFA, van Knippenberg FCE (1983) Klachtenlijst voor kankerpatiënten, eerste ervaringen. Ned Tijdschr Psychol 38:403–422
• De Haes JC, van Knippenberg FC, Neijt JP (1990) Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 62(6):1034–1038
• EORTC Quality of Life [Internet] (n.d.-a) QLQ-C30 development. Accessed 2 Oct 2023. Available in: http://groups.eortc.be/qol/qlq-c30-development
• EORTC Quality of Life [Internet] (n.d.-b) EORTC QLQ-C30. Accessed 2 Oct 2023. Available in: http://groups.eortc.be/qol/eortc-qlq-c30
• Fainsinger R, Miller MJ, Bruera E, Hanson J, Maceachern T (1991) Symptom control during the last week of life on a palliative care unit. J Palliat Care 7(1):5–11
• Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, on behalf of the EORTC Quality of Life Group (2001) The EORTC QLQ-C30 Scoring Manual, 3rd edn. Published by: European Organisation for Research and Treatment of Cancer, Brussels
• Grond S, Zech D, Diefenbach C, Bischoff A (1994) Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. J Pain Symptom Manag 9(6):372–382
• Higginson I, McCarthy M (1989) Measuring symptoms in terminal cancer: are pain and dyspnoea controlled? J R Soc Med 82(5):264–267
• Hotopf M, Chidgey J, Addington-Hall J, Ly KL (2002) Depression in advanced disease: a systematic review Part 1. Prevalence and case finding. Palliat Med 16(2):81–97
• Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 191–205
• Kristjanson LJ, Nikoletti S, Porock D, Smith M, Lobchuk M, Pedler P (1998) Congruence between patients’ and family caregivers’ perceptions of symptom distress in patients with terminal cancer. J Palliat Care 14(3):24–32
• Kurtz ME, Kurtz JC, Given CC, Given B (1996) Concordance of cancer patient and caregiver symptom reports. Cancer Pract 4(4):185–190
• Lichter I, Hunt E (1990) The last 48 hours of life. J Palliat Care 6(4):7–15
• Lobchuk MM, Degner LF (2002) Symptom experiences: perceptual accuracy between advanced-stage cancer patients and family caregivers in the home care setting. J Clin Oncol 20(16):3495–3507
• Lobchuk MM, Kristjanson L, Degner L, Blood P, Sloan JA (1997) Perceptions of symptom distress in lung cancer patients: I. Congruence between patients and primary family caregivers. J Pain Symptom Manag 14(3):136–146
• Luckett T, King MT, Butow PN et al (2011) Choosing between the EORTC QLQ-C30 and Fact-G for measuring health related quality of life in cancer clinical research: issues, evidence and recommendations. Ann Oncol 22:2179–2190
• Lyons KD, Bakitas M, Hegel MT, Hanscom B, Hull J, Ahles TA (2009) Reliability and validity of the Functional Assessment of Chronic Illness Therapy Palliative care (FACIT-Pal) scale. J Pain Symptom Manag 37(1):23–32
• Martínez P, Durá E, Andreu Y, Galdón MJ, Murgui S, Ibáñez E (2012) Structural validity and distress screening potential of the Hospital Anxiety and Depression Scale in cancer. Int J Clin Health Psychol 12(3):435–447
• McCorkle R (1987) The measurement of symptom distress. Semin Oncol Nurs 3(4):248–256
• McCorkle R, Quint-Benoliel J (1983) Symptom distress, current concerns and mood disturbance after diagnosis of the life-threatening disease. Soc Sci Med 17(7):431–438
• McCorkle R, Young K (1978) Development of a symptom distress scale. Cancer Nurs 1(5):373–378
• McMillan SC, Williams FA (1989) Validity and reliability of the Constipation Assessment Scale. Cancer Nurs 12(3):183–188
• Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK et al (1999) The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85(5):1186–1196
• Michelle M, Lobchuk RN (2003) The memorial symptom assessment scale: modified for use in understanding family caregivers’ perceptions of cancer patients’ symptom experiences. J Pain Symptom Manag 26(1):644–654
• Nelson JE, Meier DE, Oei EJ, Nierman DM, Senzel RS, Manfredi PL et al (2001) Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med 29(2):277–282
• Ng K, von Gunten CF (1998) Symptoms and attitudes of 100 consecutive patients admitted to an acute hospice/palliative care unit. J Pain Symptom Manag 16(5):307–316
• Noorani NH, Montagnini M (2007) Recognizing depression in palliative care patients. J Palliat Med 10(2):458–464
• Peruselli C, Camporesi E, Colombo AM, Cucci M, Mazzoni G, Paci E (1993) Quality of life assessment in a home care program for advanced cancer patients: a study using the symptom distress scale. J Pain Symptom Manag 8(5):306–311
• Portenoy RK, Miransky J, Thaler HT, Hornung J, Bianchi C, Cibas-Kong I et al (1992) Pain in ambulatory patients with lung or colon cancer. Prevalence, characteristics and effect. Cancer 70:1616–1624
• Portenoy RK, Thaler HT, Kornblith AB, Lepore J, Friedlander-Klar H, Coyle N et al (1994a) Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 3:183–189
• Portenoy RK, Thaler HT, Kornblith AB, McCarthy-Lepore J, Friedlander-Klar H, Kiyasu E et al (1994b) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A(9):1326–1336
• Potter J, Hami F, Bryan T, Quigley C (2003) Symptoms in 400 patients referred to palliative care services: prevalence and patterns. Palliat Med 17(4):310–314
• Pud D (2015) The psychometric properties of the Hebrew version of the memorial symptom assessment scale (MSAS-Heb) in breast cancer patients. J Pain Symptom Manag 49(4):790–795
• Regidor E, Gutiérrez-Fisac JL, de los Santos Ichaso M, Fernández E (2010) Trends in principal cancer risk factors in Spain. Ann Oncol 21 Suppl 3:iii37-42
• Samarel N, Leddy SK, Greco K, Cooley ME, Torres SC, Tulman L et al (1996) Development and testing of the symptom experience scale. J Pain Symptom Manag 12(4):221–228
• Sarna L (1993) Correlates of symptom distress in women with lung cancer. Cancer Pract 1(1):21–28
• Sociedad Española de Oncología Médica (SEOM) [Internet] (2023a) ¿Qué es el cáncer y cómo se desarrolla? Accessed 2 de October 2023]. Available in: http://www.seom.org/en/informacion-sobre-el-cancer/que-es-el-cancer-y-como-se-desarrolla
• Sociedad Española de Oncología Médica (SEOM) [Internet] (2023b) Las cifras del cáncer en España 2022. Accessed 2 de October 2023. Available in: https://seom.org/images/LAS_CIFRAS_DEL_CANCER_EN_ESPANA_2022.pdf
• Sociedad Española de Oncología Médica (SEOM) [Internet] (2023c) Las cifras del cáncer en España 2023. Accessed 2 de October 2023. Available in: https://seom.org/images/Las_cifras_del_Cancer_en_Espana_2023.pdf
• Storey P (1994) Symptom control in advanced cancer. Semin Oncol 21(6):748–753
• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108
• Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age, gender and performance status in 1000 patients. Support Care Cancer 8(3):175–179
• Woolery M, Carrol E, Fenn E, Wieland H, Jarosinski P, Corey B et al (2006) A constipation assessment scale for use in pediatric oncology. J Pediatr Oncol Nurs 23(2):65–74
• Yanez B, Pearman T, Lis CG, Beaumont JL, Cella D (2013) The FACT-GT: a rapid version of the Functional Assessment of Cancer Therapy-General (FACT-G) for monitoring symptoms and concerns in oncology practice and research. Ann Oncol 24:1073–1078
• Yates JW, Chalmer B, McKegney FP (1980) Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45(8):2220–2224
• Yildirim Y, Tokem Y, Bozcurt N, Fadiloglu C, Uyar M, Uslu R (2011) Reliability and validity of the Turkish version of the memorial symptom assessment scale in cancer patients. Asian Pac J Cancer Prev 12(12):3389–3396
• Zeng L, Bedard G, Cella D, Thavarajah N et al (2013) Preliminary results of the generation of a shortened quality-of-life assessment for patients with advanced cancer: the FACIT-Pal-14. J Palliat Med 16(5):509
• Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370